Skip to Main Content
An official website of the United States government

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Filter results of approved projects table below

Approved Projects
Name Principal Investigator Institution Study Date Approved Project ID
Improving risk stratification for lung cancer screening using peripheral blood leukocyte DNA methylation: an investigation in the National Lung Screening Trial (NLST) Dominique Michaud Tufts University NLST Nov 19, 2024 NLST-1358
Improving Risk Stratification in Stage III Colorectal Cancer: An Integrative Analysis of Tumor-Infiltrating Lymphocytes and Tumor Nuclei Features Anant Madabhushi Emory University PLCO Aug 8, 2023 PLCOI-1283
Incidence lung cancers after negative screening rounds: A retrospective review of CT findings and outcomes Jihang Kim Seoul National University Bundang Hospital NLST Dec 11, 2017 NLST-379
INCIDENCE OF LUNG CANCER IN POPULATIONS ABOVE THE AGE OF 65 DANIEL DEARMOND UTHSCSA NLST Jul 21, 2014 NLST-81
Incidence of nodal and distant metastasis in patients with lung cancer manifesting as a subsolid nodule Jihang Kim Seoul National University Bundang Hospital NLST Nov 2, 2015 NLST-174
Incidence of Second Primary Lung Cancer in Patients with a History of Head and Neck Cancer John Cramer Karmanos Cancer Institute NLST Oct 8, 2020 NLST-714
Incidence Rates of Lung and Bladder Cancer According to Smoking Status and Tumor Subtype: An Analysis of Absolute Risk in Never Smokers Sarina Murray National Cancer Institute PLCO Jan 16, 2026 PLCO-2017
Incidental Finding of Coronary Calcium (CAC) in National Lung Screening Trial participants: Its Distribution and Potential Implication Ilana Gareen School of Public Health, Brown University NLST Sep 28, 2023 NLST-1129
Incidental Thyroid Nodules and Other Incidental Findings in the NLST Hoang Jenny Duke University Medical Center NLST Feb 26, 2014 NLST-58
Incorporating Biomarkers to Improve Lung Cancer Risk Prediction Ziding Feng UT MD Anderson Cancer Center PLCO Nov 9, 2016 PLCO-239
Incorporating Biomarkers to Improve Lung Cancer Risk Prediction Samir Hanash University of Texas at MD Anderson PLCO Nov 4, 2019 PLCO-549
Incorporating Biomarkers to Improve Lung Cancer Risk Prediction ZIDING FENG UNIVERSITY OF TX MD ANDERSON CAN CTR PLCO 2015-0200
Incorporating blood biomarker with self reported exercise in PLCO cohort Ehsan Irajizad University of Texas MD Anderson Cancer Center PLCO Oct 17, 2024 PLCO-1710
Incorporating gender differences in lung cancer screening Kevin ten Haaf Erasmus MC NLST Feb 4, 2019 NLST-480
Indirect comparisons of screening strategies and generalizing effects to a nationally representative population by combining trial data Issa Dahabreh President and Fellows of Harvard College on behalf of Harvard T.H. Chan School of Public Health PLCO Dec 19, 2022 PLCO-1130
Individual and Aggregate Estimators of Socioeconomic Status in PLCO Martin Tammemagi Brock University / Henry Ford Health System PLCO Jul 1, 2006 2006-0243
Individualized-risk based computed tomography lung cancer screening strategies: an evaluation using comparative microsimulation modeling Kevin ten Haaf Erasmus MC NLST May 2, 2014 NLST-70
Individualized-risk based computed tomography lung cancer screening strategies: an evaluation using comparative microsimulation modeling Kevin ten Haaf Erasmus MC PLCO May 2, 2014 PLCO-83
Individualized treatment decisions for prostate cancer using prostate cancer specific and other-cause mortality predictors Matthew Schipper University of Michigan PLCO Aug 23, 2019 PLCO-512
Individual lung cancer survival estimation based on radiomics analysis Yujiao Wu University of Technology Sydney NLST Oct 31, 2019 NLST-596